ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Rozlytrek 200 mg, Hartkapseln - 90
67280002 Roche Pharma (Schweiz) AG
Rozlytrek 200 mg, Hartkapseln05.11.2020
  05.11.2020
Entrectinib (L01EX14) 
WHO-DDD20.07.2028
07.16.10.90
07.16.10. 
A  
Yes 
IP 
4906.67Yes
    
10 %5342.05
  
7680672800028Synthetika
  
Composition
entrectinibum 200 mg, lactosum 130 mg, cellulosum microcristallinum, acidum tartaricum, hypromellosum, crospovidonum, magnesii stearas, silica colloidalis anhydrica, Kapselhülle: hypromellosum, E 171, E 110 0.5543 mg, Drucktinte: lacca, propylenglycolum, ammoniae solutio concentrata, E 132, pro capsula.
Packungsbestandteile
Capsules 
 
Active AgentDose
Entrectinibum200 mg
BAG: Active AgentDose
Entrectinibum200 mg
 
Inactive agentsDoseadditional_information
Tartaric Acid  
Ammoniae Solutio Concentrata  
Cellulosum Microcristallinum  
Crospovidonum  
E 1100.5543 mgcolor.
E 132 color.
E 171 color.
Hypromellosum Kapselhülle
Lacca Drucktinte
Lactosum130 mg 
Magnesii Stearas  
Pro Capsula  
Propylenglycol  
Silica Colloidalis Anhydrica  
 
Source
Data was imported : 08.08.2023 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2025 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home